Sherwin-Williams SHW has been analyzed by 14 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 5 | 8 | 1 | 0 | 0 |
| Last 30D | 0 | 1 | 0 | 0 | 0 |
| 1M Ago | 3 | 5 | 1 | 0 | 0 |
| 2M Ago | 1 | 1 | 0 | 0 | 0 |
| 3M Ago | 1 | 1 | 0 | 0 | 0 |
In the assessment of 12-month price targets, analysts unveil insights for Sherwin-Williams, presenting an average target of $369.14, a high estimate of $402.00, and a low estimate of $310.00. This current average has increased by 3.56% from the previous average price target of $356.46.
Exploring Analyst Ratings: An In-Depth Overview
In examining recent analyst actions, we gain insights into how financial experts perceive Sherwin-Williams. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Greg Melich | Evercore ISI Group | Raises | Outperform | $365.00 | $360.00 |
| Patrick Cunningham | Citigroup | Lowers | Buy | $370.00 | $390.00 |
| Kenneth Zener | Keybanc | Announces | Overweight | $400.00 | - |
| Arun Viswanathan | RBC Capital | Lowers | Outperform | $370.00 | $380.00 |
| John McNulty | BMO Capital | Lowers | Outperform | $377.00 | $385.00 |
| Jeffrey Zekauskas | JP Morgan | Lowers | Overweight | $315.00 | $317.00 |
| John Roberts | Mizuho | Lowers | Buy | $334.00 | $340.00 |
| Garik Shmois | Loop Capital | Lowers | Buy | $380.00 | $395.00 |
| Ghansham Panjabi | Baird | Raises | Neutral | $310.00 | $300.00 |
| Greg Melich | Evercore ISI Group | Lowers | Outperform | $380.00 | $385.00 |
| Patrick Cunningham | Citigroup | Raises | Buy | $390.00 | $360.00 |
| Greg Melich | Evercore ISI Group | Raises | Outperform | $390.00 | $370.00 |
| John McNulty | BMO Capital | Raises | Outperform | $385.00 | $340.00 |
| Joshua Spector | UBS | Raises | Buy | $402.00 | $312.00 |
Key Insights:
- Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Sherwin-Williams. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Sherwin-Williams compared to the broader market.
- Price Targets: Delving into movements, analysts provide estimates for the future value of Sherwin-Williams's stock. This analysis reveals shifts in analysts' expectations over time.
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Sherwin-Williams's market standing. Stay informed and make well-considered decisions with our Ratings Table.
Stay up to date on Sherwin-Williams analyst ratings.
Discovering Sherwin-Williams: A Closer Look
Sherwin-Williams is the largest provider of architectural paint in the United States. The company has over 5,000 stores and sells premium paint at higher price points than most competitors. Sherwin-Williams also sells paint-related products in big-box stores and provides coatings for original equipment manufacturers.
Sherwin-Williams's Financial Performance
Market Capitalization Analysis: The company's market capitalization is above the industry average, indicating that it is relatively larger in size compared to peers. This may suggest a higher level of investor confidence and market recognition.
Negative Revenue Trend: Examining Sherwin-Williams's financials over 3 months reveals challenges. As of 31 March, 2024, the company experienced a decline of approximately -1.38% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Materials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Sherwin-Williams's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 9.41% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Sherwin-Williams's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 14.0%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Sherwin-Williams's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 2.18%, the company showcases efficient use of assets and strong financial health.
Debt Management: Sherwin-Williams's debt-to-equity ratio stands notably higher than the industry average, reaching 3.62. This indicates a heavier reliance on borrowed funds, raising concerns about financial leverage.
The Basics of Analyst Ratings
Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
